Thursday, April 28, 2022

BioMarin's Record Q1 Driven by Recently Approved Achondroplasia Therapy | BioSpace

Durability, or staying power, is a running concern in the gene therapy space. In March, however, BioMarin published optimistic Phase III results ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...